A comparative study on metabolic syndrome in patients with schizophrenia treated using first-generation and second-generation antipsychotics
Introduction: The prevalence of metabolic syndrome is more in patients with schizophrenia receiving first- and second-generation antipsychotics. Aim and Objectives: The aim is to study the prevalence of metabolic syndrome in patients with schizophrenia treated with first-generation and second-genera...
Main Authors: | Dinesh Panati, T P Sudhakar, Puthalapattu Swetha, Vinay Kumar Sayeli |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Archives of Mental Health |
Subjects: | |
Online Access: | http://www.amhonline.org/article.asp?issn=2589-9171;year=2020;volume=21;issue=1;spage=4;epage=11;aulast=Panati |
Similar Items
-
Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
by: Fang X, et al.
Published: (2019-07-01) -
Glucoregulation in normal weight schizophrenia patients treated by first generation antipsychotics
by: Marić Nađa, et al.
Published: (2008-01-01) -
Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
by: Anastasiia S. Boiko, et al.
Published: (2021-05-01) -
Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications
by: M S Karthik, et al.
Published: (2014-01-01) -
Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia
by: Zachary Freyberg, et al.
Published: (2017-07-01)